Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICCM NASDAQ:IRIX OTCMKTS:USAQ NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.22-4.0%$0.32$0.21▼$1.40$17.79M0.47611,997 shs840,604 shsIRIXIRIDEX$1.05+1.9%$1.07$0.87▼$1.65$18.28M0.6455,592 shs66,995 shsUSAQQHSLab$0.57+22.0%$0.60$0.08▼$1.14$6.38M0.481,721 shs3,700 shsZJYLJin Medical International$2.24+2.3%$2.17$1.64▼$17.18$17.53M7.526,895 shs5,846 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical0.00%-6.81%-23.43%-62.10%-78.74%IRIXIRIDEX0.00%+3.96%+1.94%-25.00%+10.76%USAQQHSLab0.00%+8.77%+6.22%-19.20%+133.72%ZJYLJin Medical International0.00%-5.45%+6.16%-22.81%-85.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.22-4.0%$0.32$0.21▼$1.40$17.79M0.47611,997 shs840,604 shsIRIXIRIDEX$1.05+1.9%$1.07$0.87▼$1.65$18.28M0.6455,592 shs66,995 shsUSAQQHSLab$0.57+22.0%$0.60$0.08▼$1.14$6.38M0.481,721 shs3,700 shsZJYLJin Medical International$2.24+2.3%$2.17$1.64▼$17.18$17.53M7.526,895 shs5,846 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical0.00%-6.81%-23.43%-62.10%-78.74%IRIXIRIDEX0.00%+3.96%+1.94%-25.00%+10.76%USAQQHSLab0.00%+8.77%+6.22%-19.20%+133.72%ZJYLJin Medical International0.00%-5.45%+6.16%-22.81%-85.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICCMIceCure Medical 2.40Hold$2.09854.34% UpsideIRIXIRIDEX 2.00Hold$3.00185.71% UpsideUSAQQHSLab 0.00N/AN/AN/AZJYLJin Medical International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest USAQ, ICCM, IRIX, and ZJYL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/14/2026ICCMIceCure Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $1.005/4/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/4/2026ICCMIceCure Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy4/21/2026ICCMIceCure Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/15/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)(Data available from 5/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICCMIceCure Medical$3.38M5.26N/AN/A$0.10 per share2.19IRIXIRIDEX$52.67M0.35N/AN/A($0.07) per share-15.00USAQQHSLab$2.69M2.37N/AN/A$0.13 per share4.35ZJYLJin Medical International$20.69M0.85$0.18 per share12.23$3.78 per share0.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICCMIceCure Medical-$15.06M-$0.24N/AN/AN/A-441.60%-211.73%-119.13%8/12/2026 (Estimated)IRIXIRIDEX-$4.44M-$0.19N/AN/AN/A-6.23%-1,204.74%-11.16%8/6/2026 (Estimated)USAQQHSLab$460K$0.0318.86N/AN/A15.60%-27.74%-6.98%8/19/2026 (Estimated)ZJYLJin Medical International$1.19MN/AN/AN/AN/AN/AN/AN/AN/ALatest USAQ, ICCM, IRIX, and ZJYL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026IRIXIRIDEX-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million5/12/2026Q1 2026ICCMIceCure Medical-$0.03-$0.06-$0.03$0.06$1.34 million$0.91 million3/26/2026Q4 2025IRIXIRIDEX-$0.02-$0.01+$0.01-$0.01$14.74 million$14.72 million3/17/2026Q4 2025ICCMIceCure Medical-$0.04-$0.06-$0.02-$0.0620$1.30 million$1.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthICCMIceCure MedicalN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICCMIceCure MedicalN/A2.521.97IRIXIRIDEXN/A1.921.19USAQQHSLabN/A1.681.61ZJYLJin Medical InternationalN/A1.861.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICCMIceCure Medical0.62%IRIXIRIDEX20.10%USAQQHSLabN/AZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipICCMIceCure Medical2.44%IRIXIRIDEX8.60%USAQQHSLab74.19%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICCMIceCure Medical6081.24 million79.26 millionNot OptionableIRIXIRIDEX12017.41 million15.91 millionOptionableUSAQQHSLab511.28 million2.91 millionNot OptionableZJYLJin Medical International2457.83 millionN/ANot OptionableUSAQ, ICCM, IRIX, and ZJYL HeadlinesRecent News About These CompaniesHead to Head Comparison: Resonate Blends (OTCMKTS:KOAN) and Jin Medical International (NASDAQ:ZJYL)May 28 at 4:28 AM | americanbankingnews.comJin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share SplitApril 10, 2026 | theglobeandmail.comJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementApril 7, 2026 | prnewswire.comJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance InitiativeMarch 11, 2026 | prnewswire.comJin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse SplitsFebruary 7, 2026 | theglobeandmail.comJin Medical CEO Fireside ChatFebruary 5, 2026 | prnewswire.comJin Medical to Host February 1 Fireside Chat as It Revamps Corporate WebsiteJanuary 28, 2026 | tipranks.comJin Medical International Ltd. To Host Management Fireside ChatJanuary 26, 2026 | prnewswire.comJin Medical Sets April Launch for High-Capacity Chuzhou Mobility Device PlantJanuary 22, 2026 | tipranks.comJin Medical Announces the Official Commencement Date of Chuzhou FacilityJanuary 22, 2026 | prnewswire.comJin Medical International Ltd. Management Plans For Fireside ChatJanuary 21, 2026 | finance.yahoo.comJin Medical International Ltd. to Host Fireside Chat on Strategic Priorities and Capital Structure on February 1, 2026January 21, 2026 | quiverquant.comQJin Medical Calls January 30 EGM to Restructure Share Capital and Adopt New Equity PlanJanuary 8, 2026 | tipranks.comJin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?November 22, 2025 | defenseworld.netDAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comJin Medical International (NASDAQ:ZJYL) Will Want To Turn Around Its Return TrendsAugust 25, 2025 | finance.yahoo.comJin Medical International Reports Decline in Revenue and Profit for H1 2025August 20, 2025 | msn.comJin Medical International Ltd News (ZJYL) - Investing.comAugust 20, 2025 | investing.comJin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, ChinaJuly 15, 2025 | quiverquant.comQJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing FacilityJuly 15, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUSAQ, ICCM, IRIX, and ZJYL Company DescriptionsIceCure Medical NASDAQ:ICCM$0.22 -0.01 (-3.99%) Closing price 05/29/2026 04:00 PM EasternExtended Trading$0.22 0.00 (-1.37%) As of 05/29/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.IRIDEX NASDAQ:IRIX$1.05 +0.02 (+1.94%) Closing price 05/29/2026 04:00 PM EasternExtended Trading$1.05 0.00 (0.00%) As of 05/29/2026 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.QHSLab OTCMKTS:USAQ$0.57 +0.10 (+21.98%) As of 05/29/2026 02:43 PM EasternQHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.Jin Medical International NASDAQ:ZJYL$2.24 +0.05 (+2.28%) Closing price 05/29/2026 04:00 PM EasternExtended Trading$2.24 0.00 (0.00%) As of 05/29/2026 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/25 - 05/29 Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17% Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem MongoDB's AI Advantage Is Starting to Show Up in Results Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys Dollar Tree Keeps Winning After Family Dollar Divorce Salesforce Stock Finds Support as AI Momentum Builds These 3 Software Stocks Are Buying Back Shares Hand Over Fist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
